Olympus America

Press Center

Olympus Broadens Portfolio with New Biliary Metallic Stent

Breakthrough Design Improves Anatomic Conformability and Radial Support

CENTER VALLEY, Pa., June 1, 2009 – Olympus America Inc. today expanded its medical portfolio by introducing the X-Suit NIR®, a biliary metallic stent designed with exceptional anatomic conformability and superior radial support. The X-Suit NIR’s proprietary NIRflex™ cell design provides a physician support and flexibility; both critical to help relieve the symptoms associated with pancreatic, liver and bile duct cancers. 

The NIRflex™ advanced cell design biliary metallic stent provides flexible construction to fit the shape of any biliary duct. Constructed of Nitinol, the stent is water-jet cut and electro-polished for much greater durability. Each strut is also rounded, helping to reduce stress to the tissue and prevent damage to the bile duct and duodenal walls. 

“Olympus provides the most extensive line of GI products and services in the industry,” said Eric Halvorson, chief marketing officer, Medical Systems Group, Olympus America, Inc. “X-Suit is a good example of how Olympus remains dedicated to expanding its offerings and working with the world’s top medical experts to provide solutions that best suit the needs of its customers and their patients.”

To ensure precise placement of the stent during a therapeutic procedure, the X-Suit NIR® has virtually no foreshortening. In addition, each end of the stent features five radiopaque markers that allow physicians to determine the position of the stent under an X-ray prior to deployment. A black marker is positioned at the proximal end of the stent facilitating endoscopic confirmation of the stent during deployment. The ease of deployment combined with superior radial support makes the X-Suit NIR® the stent of choice for re-establishing biliary flow.

About Olympus Medical Systems Group
Olympus Medical Systems Group is a leader in the advancement of less invasive patient care.  Olympus, which now includes surgical market leader Gyrus ACMI, provides knowledge and solutions in the areas of advanced diagnostic and therapeutic endoscopy, early-stage cancer evaluation and treatment, and innovative, less invasive surgical procedures.  Olympus is continually dedicated to elevating standards of patient care to deliver earlier detection, faster and better treatment, improved outcomes and enhanced quality of life.

ABOUT OLYMPUS
Olympus is a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products.

Olympus works collaboratively with its customers and its affiliates worldwide to leverage R&D investment in precision technology and manufacturing processes across diverse business lines.  These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced clinical and research microscopes;
  • Lab automation systems, chemistry-immuno and blood bank analyzers and reagents;
  • Digital cameras and voice recorders.

Olympus serves healthcare and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers to efficiently, reliably and more easily achieve exceptional results.  Olympus develops breakthrough technologies with revolutionary product design and functionality for the consumer and professional photography markets, and also is the leader in gastrointestinal endoscopy and clinical and educational microscopes.  For more information, visit www.olympusamerica.com

NIR is a registered trademark of Medinol, Ltd.
NIRFlex is a trademark of Medinol, Ltd.